INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nutanix, Inc. - NTNX

08.01.26 16:00 Uhr

Werte in diesem Artikel
Aktien

45,94 EUR 0,44 EUR 0,97%

NEW YORK, Jan. 8, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Nutanix, Inc. ("Nutanix" or the "Company") (NASDAQ: NTNX).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

Fighting for victims of securities fraud for more than 85 years (PRNewsfoto/Pomerantz LLP)

The investigation concerns whether Nutanix and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

[Click here for information about joining the class action]

On November 25, 2025, Nutanix reported its financial results for the first quarter of fiscal year 2026, including revenue near the bottom end of the Company's prior guidance.  Nutanix attributed the results to a late quarter "revenue shift from Q1 to future periods" caused by increased customer demand for flexible start dates and the growth of Nutanix's business through third-party original equipment manufacturer partners.  As a result, Nutanix lowered its full-year revenue projection from a range of $2.9 billion to $2.94 billion to a range of $2.82 billion to $2.86 billion.  

On this news, Nutanix's stock price fell $10.43 per share, or 17.8%, to close at $48.34 per share on November 26, 2025.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.

Attorney advertising. Prior results do not guarantee similar outcomes. 

CONTACT:
Danielle Peyton
Pomerantz LLP
dpeyton@pomlaw.com
646-581-9980 ext. 7980

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-nutanix-inc---ntnx-302654914.html

SOURCE Pomerantz LLP

In eigener Sache

Übrigens: Nutanix A und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf Nutanix A

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Nutanix A

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Nachrichten zu Nutanix Inc (A)

Wer­bung

Analysen zu Nutanix Inc (A)

DatumRatingAnalyst
31.05.2019Nutanix A BuyNeedham & Company, LLC
22.03.2019Nutanix A BuyMaxim Group
01.03.2019Nutanix A BuyMaxim Group
01.03.2019Nutanix A BuyNeedham & Company, LLC
28.11.2018Nutanix A BuyNeedham & Company, LLC
DatumRatingAnalyst
31.05.2019Nutanix A BuyNeedham & Company, LLC
22.03.2019Nutanix A BuyMaxim Group
01.03.2019Nutanix A BuyMaxim Group
01.03.2019Nutanix A BuyNeedham & Company, LLC
28.11.2018Nutanix A BuyNeedham & Company, LLC
DatumRatingAnalyst
11.01.2017Nutanix A Sector PerformFBN Securities
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Nutanix Inc (A) nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen